logo.jpg
Helsinn Group appoints Riccardo Carbucicchio to the Board of Directors
September 19, 2024 08:00 ET | Helsinn Healthcare S.A.
Helsinn Group appoints Riccardo Carbucicchio to the Board of Directors Lugano, Switzerland – September 19, 2024 – Helsinn Group (“Helsinn”), a global pharmaceutical company with a track record of...
logo.jpg
Helsinn Group announces AKYNZEO® (fosnetupitant/palonosetron) injection is now available in a ready-to-use vial in the US
June 24, 2024 08:00 ET | Helsinn Healthcare S.A.
Helsinn Group announces AKYNZEO® (fosnetupitant/palonosetron) injection is now available in a ready-to-use vial in the US Lugano, Switzerland – June 24, 2024 – Helsinn Group (“Helsinn”), a global...
logo.jpg
Helsinn Group and Chugai Pharma Europe sign a partnership agreement renewal to commercialize AKYNZEO® in the UK and Ireland
June 12, 2024 05:00 ET | Helsinn Healthcare S.A.
Helsinn Group and Chugai Pharma Europe sign a partnership agreement renewal to commercialize AKYNZEO® in the UK and Ireland Lugano, Switzerland – June 12, 2024 – Helsinn Group (“Helsinn”), a global...
logo.jpg
Helsinn and Angelini Pharma sign a partnership agreement renewal to commercialize AULIN® and MESULID® in Bulgaria, Czech Republic, Hungary, Poland, Romania and Slovak Republic
May 27, 2024 05:00 ET | Helsinn Healthcare S.A.
Helsinn and Angelini Pharma sign a partnership agreement renewal to commercialize AULIN® and MESULID® in Bulgaria, Czech Republic, Hungary, Poland, Romania and Slovak Republic Lugano...
Research Nester Logo.jpg
Vaso Occlusive Crisis Market revenue to surpass USD 20 Billion by 2036, says Research Nester
December 06, 2023 06:30 ET | Research Nester
New York, Dec. 06, 2023 (GLOBE NEWSWIRE) -- The global vaso occlusive crisis market size is projected to expand at 8% CAGR between 2024 and 2036. The market is expected to garner a revenue of USD 20...
MicrosoftTeams-image (5).png
Acute Kidney Injury Treatment Market to Reach US$ 3 Bn by 2031, TMR Study
December 01, 2022 09:30 ET | Transparency Market Research
Wilmington, Delaware, United States, Dec. 01, 2022 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. - The acute kidney injury treatment market stood at US$ 1.5 Bn in 2021. TMR projects that the...
CC2.png
ChemioCare Reports Positive Animal Study Results for CMIO-Ondan Patch
February 06, 2019 08:29 ET | ChemioCare
NEW YORK, Feb. 06, 2019 (GLOBE NEWSWIRE) -- ChemioCare USA Inc. (“ChemioCare” or the “Company”), a platform company based on proprietary transdermal delivery, today announced the minipig safety and...
CC2.png
ChemioCare Initiates Development Program in Pediatric CINV
January 04, 2019 17:52 ET | ChemioCare
NEW YORK, Jan. 04, 2019 (GLOBE NEWSWIRE) -- ChemioCare USA Inc. (“ChemioCare” or the “Company”), a platform company focused on proprietary transdermal delivery today announced that its Adult...
Filament BioSolutions Announces Collaboration with Ajinomoto for the Development of FB-2710 for Radiation-Induced Oral Mucositis
July 10, 2018 07:30 ET | Filament BioSolutions, Inc.
NEW YORK, July 10, 2018 (GLOBE NEWSWIRE) -- Filament BioSolutions, a development-stage company focused on delivering innovative therapeutics for nutritional deficiencies, announced today continued...